Kenneth Tripp

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Philip Schoenfeld, Brian E. Lacy, William D. Chey et al. · The American Journal of Gastroenterology · 2017 · 75 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

William D. Chey, Gregory S. Sayuk, Wilmin Bartolini et al. · The American Journal of Gastroenterology · 2020 · 55 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial

William E. Berger, Henry Milgrom, David P. Skoner et al. · Current Medical Research and Opinion · 2006 · 26 citations

Medicine, Pediatrics, Pharmacology +17

A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects

Kenneth Tripp, William K McVicar, Parameswaran Nair et al. · Journal of Allergy and Clinical Immunology · 2008 · 19 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis

Judy Nee, Jeffrey M. Johnston, Elizabeth P. Shea et al. · Expert Review of Gastroenterology & Hepatology · 2019 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16